AIM2 inflammasome
Selected indexed studies
- AIM2 Inflammasome Assembly and Signaling. (Adv Exp Med Biol, 2019) [PMID:31628655]
- AIM2 inflammasome: A potential therapeutic target in ischemic stroke. (Clin Immunol, 2024) [PMID:38142900]
- AIM2-inflammasome role in systemic lupus erythematous and rheumatoid arthritis. (Autoimmunity, 2022) [PMID:35880661]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- AIM2 Inflammasome Assembly and Signaling. (2019) pubmed
- AIM2 inflammasome: A potential therapeutic target in ischemic stroke. (2024) pubmed
- AIM2-inflammasome role in systemic lupus erythematous and rheumatoid arthritis. (2022) pubmed
- Oxysterol Restraint of Cholesterol Synthesis Prevents AIM2 Inflammasome Activation. (2017) pubmed
- AIM2 inflammasome contributes to brain injury and chronic post-stroke cognitive impairment in mice. (2020) pubmed
- Pristimerin suppresses AIM2 inflammasome by modulating AIM2-PYCARD/ASC stability via selective autophagy to alleviate tendinopathy. (2024) pubmed
- AIM2 Inflammasome's First Decade of Discovery: Focus on Oral Diseases. (2020) pubmed
- Integrated NLRP3, AIM2, NLRC4, Pyrin inflammasome activation and assembly drive PANoptosis. (2023) pubmed
- Perfluoroalkyl substance pollutants activate the innate immune system through the AIM2 inflammasome. (2021) pubmed
- AIM2 in health and disease: Inflammasome and beyond. (2020) pubmed